Select Page

Lung Cancer News Update

FDA approves alectinib as adjuvant treatment for ALK-positive non-small cell lung cancer “On April 18, 2024, the Food and Drug Administration approved alectinib (Alecensa, Genentech, Inc.) for adjuvant treatment following tumor resection in patients with anaplastic...

Hepatitis C News Update

‘Doctors told me I’d die before I left school’“”If you’re lucky, you have about two years. But you probably won’t live long enough to leave school.” Those were the words Mark Ward says he will never forget hearing from a...

My Choices News Update

Exercise may reduce heart disease risk by changing how the brain reacts to stress“Physical activity can help reduce the chances of cardiovascular disease by affecting stress responses in the brain, according to a new study. The researchers found that those who met the...

Hepatitis C News Update

Deaths From Viral Hepatitis Are on the Rise“Viral hepatitis is now the second leading infectious cause of death globally after tuberculosis, the World Health Organization’s report reveals. Viral hepatitis testing and treatment coverage rates have stalled despite...

Lung Cancer News Update

Radon Gas Exposure May Be Linked to Increased Incidence of Lung Cancer in Nonsmokers“Long-term exposure to radon gas may be associated with a rise in nonsmoking lung cancer cases, according to a recent consumer survey conducted on behalf of The Ohio State University...